Treasuries See U.S. Falling Over Cliff as Yields Converge – Bloomberg 11-13-12

Salient to Investors: JPMorgan Chase said the drop in the yield on 10-yr Treasuries below 1.7 percent indicates investors expect GDP to fall 0.3 percent next year as the fiscal cliff takes effect. Terry Belton at JPMorgan Chase continues to believe that Congress avoids the fiscal cliff. Priya Misra at Bank of America Merrill Lynch

READ MORE...

Home Depot Profit Tops Estimates as Housing Market Heals – Bloomberg 11-13-12

Salient to Investors: Home Depot Q3 profit topped analysts’ estimates. The US housing market is healing, with new-home sales rising to the fastest pace in two years and construction starting at the fastest rate in four years. Americans’ real estate holdings have risen in value for two straight quarters. CoreLogic said over

READ MORE...

Hispanic Workers Lack Education as Numbers Grow in U.S. – Bloomberg 11-13-12

Salient to Investors: Hispanics are the fastest growing component of America’s workforce, yet over 80 percent of Latinos ages 25 and older don’t have a bachelor’s degree, and the unemployment rate for Hispanics was 10 percent in October versus 7.9 percent nationally. The  National Center for Education Statistics says 14 percent of Hispanics ages

READ MORE...

DeMark Fibonacci Charts Embraced by Cohen Lure Investors – Bloomberg 11-12-13

Salient to Investors: David Goel at Matrix Capital Mgmt said DeMark’s algorithms are much more predictive than any other system. Tom DeMark’s says fundamentals do matter, and markets are governed by waves that crest and fall based on Fibonacci numbers and the closely related golden mean, or golden ratio 1.618. DeMark can’t explain why his

READ MORE...

Insider Mulls Suicide as Health Care Tipping Wave Grows – Bloomberg 11-12-12

Salient to Investors: Markets are awash in insider trading, and healthcare has been particularly hard-hit since it offers illegal traders more opportunities to profit than the finance and technology sectors. Health companies can live or die on the results of drug trials and the industry has undergone significant consolidation. What’s notable about

READ MORE...